Molecular immune signatures of HIV-1 vaccines in human PBMCs
- PMID: 19665024
- PMCID: PMC3418664
- DOI: 10.1016/j.febslet.2009.07.060
Molecular immune signatures of HIV-1 vaccines in human PBMCs
Abstract
The global transcriptional profile of peripheral blood mononuclear cells (PBMCs) stimulated with HIV candidate vaccine (virus-like particles, VLPs) has been evaluated in HIV-infected patients with low/high viral load compared to healthy volunteers. Baseline activation of chemokine production was observed in PBMC from HIV-infected patients and innate immune stimulation with HIV-VLPs was not blunted. The immune profile among HIV-infected patients was found to be qualitatively similar but quantitatively extremely variable. This diversity was independent of viral load and it might be dependent on individual immunogenetic traits or concurrent immunological status. This ex vivo screening strategy represents an efficient tool for guiding modifications/optimizations of vaccination strategies and understanding failures in individuals enrolled in clinical trials.
Figures





Similar articles
-
Gene expression profile of peripheral blood mononuclear cells in response to HIV-VLPs stimulation.BMC Bioinformatics. 2008 Mar 26;9 Suppl 2(Suppl 2):S5. doi: 10.1186/1471-2105-9-S2-S5. BMC Bioinformatics. 2008. PMID: 18387207 Free PMC article.
-
Short communication: limited induction of IL-10 in PBMCs from HIV-infected subjects treated with HIV-VLPs.AIDS Res Hum Retroviruses. 2009 Aug;25(8):819-22. doi: 10.1089/aid.2008.0304. AIDS Res Hum Retroviruses. 2009. PMID: 19630502 Free PMC article.
-
Endotoxemia is associated with altered innate and adaptive immune responses in untreated HIV-1 infected individuals.PLoS One. 2011;6(6):e21275. doi: 10.1371/journal.pone.0021275. Epub 2011 Jun 24. PLoS One. 2011. PMID: 21731690 Free PMC article.
-
Design Concepts of Virus-Like Particle-Based HIV-1 Vaccines.Front Immunol. 2020 Sep 30;11:573157. doi: 10.3389/fimmu.2020.573157. eCollection 2020. Front Immunol. 2020. PMID: 33117367 Free PMC article. Review.
-
Particle-based vaccines for HIV-1 infection.Curr Drug Targets Infect Disord. 2003 Jun;3(2):151-69. doi: 10.2174/1568005033481213. Curr Drug Targets Infect Disord. 2003. PMID: 12769792 Review.
Cited by
-
Pattern of activation of human antigen presenting cells by genotype GII.4 norovirus virus-like particles.J Transl Med. 2013 May 24;11:127. doi: 10.1186/1479-5876-11-127. J Transl Med. 2013. PMID: 23705987 Free PMC article.
-
Systems Biology Approach for Cancer Vaccine Development and Evaluation.Vaccines (Basel). 2015 Jul 14;3(3):544-55. doi: 10.3390/vaccines3030544. Vaccines (Basel). 2015. PMID: 26350594 Free PMC article. Review.
-
Microarray analysis of microRNA expression in peripheral blood mononuclear cells of critically ill patients with influenza A (H1N1).BMC Infect Dis. 2013 Jun 3;13:257. doi: 10.1186/1471-2334-13-257. BMC Infect Dis. 2013. PMID: 23731466 Free PMC article.
-
Systems biology applied to vaccine and immunotherapy development.BMC Syst Biol. 2011 Sep 20;5:146. doi: 10.1186/1752-0509-5-146. BMC Syst Biol. 2011. PMID: 21933421 Free PMC article. Review.
-
Peripheral blood RNA expression profiling in illicit methcathinone users reveals effect on immune system.Front Genet. 2011 Aug 19;2:42. doi: 10.3389/fgene.2011.00042. eCollection 2011. Front Genet. 2011. PMID: 22303338 Free PMC article.
References
-
- Buonaguro L, Buonaguro FM, Tornesello ML, Mantas D, Beth-Giraldo E, Wagner R, Michelsonr S, Prevost M-C, Wolf H, Giraldo G. High efficient production of Pr55gag Virus-like Particles expressing multiple HIV-1 epitopes, including a gp120 protein derived from an Ugandan HIV-1 isolate of subtype A. Antiviral Res. 2001;49:35–47. - PubMed
-
- Buonaguro L, Racioppi L, Tornesello ML, Arra C, Visciano ML, Biryahwaho B, Sempala SDK, Giraldo G, Buonaguro FM. Induction of neutralizing antibodies and CTLs in Balb/c mice immunized with Virus-like Particles presenting a gp120 molecule from a HIV-1 isolate of clade A (HIV-VLPAs) Antiviral Res. 2002;54:189–201. - PubMed
-
- Buonaguro L, Visciano ML, Tornesello ML, Tagliamonte M, Biryahwaho B, Buonaguro FM. Induction of systemic and mucosal cross-clade neutralizing antibodies in BALB/c mice immunized with human immunodeficiency virus type 1 clade A virus-like particles administered by different routes of inoculation. J. Virol. 2005;79:7059–7067. - PMC - PubMed
-
- Buonaguro L, Devito C, Tornesello ML, Schroder U, Wahren B, Hinkula J, Buonaguro FM. DNA-VLP prime-boost intra-nasal immunization induces cellular and humoral anti-HIV-1 systemic and mucosal immunity with cross-clade neutralizing activity. Vaccine. 2007;25:5968–5977. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources